MedTrace Logo

A Study of Robot-Assisted Bronchoscopy in Chinese Participants With Lung Lesions

NCT05426213 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-02-03

No results posted yet for this study

Summary

Robot-assisted bronchoscopy biopsy procedure will be conducted for all eligible subjects under general anesthesia status by trained investigators in hospital.

Conditions

  • Lung Neoplasms

Interventions

DEVICE

Robot-assisted Bronchoscopy (Monarch Platform)

Robotic assisted bronchoscopy biopsy procedures will be performed using the Monarch platform.

Sponsors & Collaborators

  • Auris Health, Inc.

    lead INDUSTRY

Principal Investigators

  • Auris Health, Inc. Clinical Trial · Auris Health, Inc.

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-12
Primary Completion
2023-09-15
Completion
2024-09-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05426213 on ClinicalTrials.gov